Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting the METTL3-METTL14 Complex Alleviates Macrophage-Mediated Inflammation. | Tohoku J Exp Med | 2026 | 41708093 | PubTator, text mining | PubMed |
| METTL14 modulates the nasopharyngeal carcinoma microenvironment via m6A-modified YWHAH identified through single-cell and machine learning analyses. | Front Immunol | 2026 | 41705255 | PubTator, text mining | PubMed |
| Coordinated DNA methyltransferase 3A and methyltransferase-like 7A activity reprograms the tumor microenvironment through discoidin domain receptor 1 signaling. | Cancer Biol Med | 2026 | 41700824 | PubTator, text mining | PubMed |
| Xinfeng capsule improves hyperinflammation-associated hypercoagulability and self-perception in osteoarthritis by regulating KLF4 through METTL14-mediated m6A modification of lncRNA MEG3. | Front Immunol | 2026 | 41694352 | PubTator, text mining | PubMed |
| Nervous necrosis virus capsid protein antagonizes methyltransferase-like 14-mediated m6A modification of mitochondrial antiviral signaling protein to evade antiviral immunity in Lateolabrax japonicus. | Int J Biol Macromol | 2026 | 41690345 | PubTator, text mining | PubMed |
| The METTL14/YTHDF3 axis regulates EPSTI1-mediated osteogenic differentiation of human bone marrow mesenchymal stem cells. | Tissue Cell | 2026 | 41690067 | PubTator, text mining | PubMed |
| Association of METTL14 expression with prognosis and immunotherapy in breast cancer. | Transl Cancer Res | 2026 | 41674959 | PubTator, text mining | PubMed |
| Emerging insights into enhancer RNAs: biogenesis, function, mechanism, and disease implication. | Brief Bioinform | 2026 | 41652928 | PubTator, text mining | PubMed |
| Integrative bioinformatics and machine learning approaches identify novel diagnostic signatures for oxaliplatin-resistant colorectal cancer. | Int J Colorectal Dis | 2026 | 41642369 | PubTator, text mining | PubMed |
| Oncolytic viruses: advanced strategies in cancer therapy. | Signal Transduct Target Ther | 2026 | 41639062 | PubTator, text mining | PubMed |
| N6-methyladenosine RNA methylation regulators and their target SOX2 as circulating biomarkers of colorectal cancer: Insights towards early diagnosis and staging. | Comput Biol Med | 2026 | 41621400 | PubTator, text mining | PubMed |
| METTL14 promotes ischemic stroke pathogenesis by mediating m6A methylation modification of BACH1 to enhance OGD/R-induced neuronal damage and facilitate ferroptosis in SK-N-SH cells. | Neuroscience | 2026 | 41616954 | PubTator, text mining | PubMed |
| Redox-sensitive N6-methyladenosine RNA epitranscriptomic mechanisms in environmental stress and hazard. | Redox Biol | 2026 | 41616571 | PubTator, text mining | PubMed |
| The role of m6A RNA methyltransferase METTL3 in drug resistance mechanisms in acute myeloid leukemia. | Blood Res | 2026 | 41615563 | PubTator, text mining | PubMed |
| COL23A1 promotes tumor progression and glycolytic reprogramming in endometrial cancer via METTL14-m6A-YTHDF1 axis. | Cytotechnology | 2026 | 41613302 | PubTator, text mining | PubMed |
| The SAM-m6A axis as an unexplored therapeutic hub for plant-derived regulation of disease metabolism. | Pharmacol Res | 2026 | 41611142 | PubTator, text mining | PubMed |
| Acute myeloid leukemia (AML)-derived bone mesenchymal stem cell exosomal METTL14 promotes AML cell growth and glycolysis by HOXA3/WNT7B axis. | Cell Biol Toxicol | 2026 | 41609866 | PubTator, text mining | PubMed |
| RNA Processing in Cardiac Hypertrophy: Coordinating Physiological Adaptation and Pathological Remodeling. | FASEB J | 2026 | 41609009 | PubTator, text mining | PubMed |
| Epigenetic and post-translational regulatory networks of ferroptosis in the tumor immune microenvironment. | Exp Hematol Oncol | 2026 | 41588554 | PubTator, text mining | PubMed |
| Single-cell and machine learning approaches reveal METTL14-mediated autophagy via PI3K/AKT signaling in invasive PitNET. | Cancer Cell Int | 2026 | 41588537 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=8